IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort
- PMID: 18757973
- PMCID: PMC2806573
- DOI: 10.1192/bjp.bp.108.051904
IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort
Abstract
Background: Non-clinical psychotic symptoms appear common in children, but it is possible that a proportion of reported symptoms result from misinterpretation. There is a well-established association between pre-morbid low IQ score and schizophrenia. Psychosis-like symptoms in children may also be a risk factor for psychotic disorder but their relationship with IQ is unclear.
Aims: To investigate the prevalence, nature and frequency of psychosis-like symptoms in 12-year-old children and study their relationship with IQ.
Method: Longitudinal study using the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort. A total of 6455 children completed screening questions for 12 psychotic symptoms followed by a semi-structured clinical assessment. IQ was assessed at 8 years of age using the Wechsler Intelligence Scale for Children (3rd UK edition).
Results: The 6-month period prevalence for one or more symptoms was 13.7% (95% CI 12.8-14.5). After adjustment for confounding variables, there was a non-linear association between IQ score and psychosis-like symptoms, such that only those with below average IQ score had an increased risk of reporting such symptoms.
Conclusions: Non-clinical psychotic symptoms occur in a significant proportion of 12-year-olds. Symptoms are associated with low IQ and also less strongly with a high IQ score. The pattern of association with IQ differs from that observed in schizophrenia.
Figures
Similar articles
-
IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study.Am J Psychiatry. 1998 May;155(5):672-7. doi: 10.1176/ajp.155.5.672. Am J Psychiatry. 1998. PMID: 9585720
-
The association between early autistic traits and psychotic experiences in adolescence.Schizophr Res. 2012 Mar;135(1-3):164-9. doi: 10.1016/j.schres.2011.11.037. Epub 2012 Jan 13. Schizophr Res. 2012. PMID: 22245185
-
Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort.Psychol Med. 2009 Sep;39(9):1457-67. doi: 10.1017/S0033291708005126. Epub 2009 Feb 12. Psychol Med. 2009. PMID: 19215630
-
Association of measures of fetal and childhood growth with non-clinical psychotic symptoms in 12-year-olds: the ALSPAC cohort.Br J Psychiatry. 2009 Jun;194(6):521-6. doi: 10.1192/bjp.bp.108.051730. Br J Psychiatry. 2009. PMID: 19478292 Free PMC article.
-
Psychotic symptoms in pediatric bipolar disorder.J Affect Disord. 2004 May;80(1):19-28. doi: 10.1016/S0165-0327(03)00053-3. J Affect Disord. 2004. PMID: 15094254 Review.
Cited by
-
Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis.Schizophr Res. 2013 Dec;151(1-3):141-7. doi: 10.1016/j.schres.2013.10.003. Epub 2013 Oct 22. Schizophr Res. 2013. PMID: 24156901 Free PMC article.
-
A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence.Psychol Med. 2014 Nov;44(15):3229-38. doi: 10.1017/S0033291714000750. Epub 2014 Apr 25. Psychol Med. 2014. PMID: 25066026 Free PMC article.
-
A population-based study of genetic variation and psychotic experiences in adolescents.Schizophr Bull. 2014 Nov;40(6):1254-62. doi: 10.1093/schbul/sbt146. Epub 2013 Oct 30. Schizophr Bull. 2014. PMID: 24174267 Free PMC article.
-
Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes.Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):654-64. doi: 10.1002/ajmg.b.32270. Epub 2014 Sep 16. Am J Med Genet B Neuropsychiatr Genet. 2014. PMID: 25228436 Free PMC article.
-
Association of Trauma Type, Age of Exposure, and Frequency in Childhood and Adolescence With Psychotic Experiences in Early Adulthood.JAMA Psychiatry. 2019 Jan 1;76(1):79-86. doi: 10.1001/jamapsychiatry.2018.3155. JAMA Psychiatry. 2019. PMID: 30477014 Free PMC article.
References
-
- Bijl R, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587–95. - PubMed
-
- Jenkins R, Bebbington P, Brugha T, Farrell M, Gill B, Lewis G, Meltzer H, Petticrew M. The National Psychiatric Morbidity Surveys of Great Britain – strategy and methods. Int Rev Psychiatry 2003; 15: 5–13. - PubMed
-
- Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996; 53: 1022–31. - PubMed
-
- Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19. - PubMed
-
- Offord D, Boyle M, Campbell D, Goering P, Racine Y. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 1996; 41: 559–63. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical